<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548833</url>
  </required_header>
  <id_info>
    <org_study_id>A00924</org_study_id>
    <nct_id>NCT01548833</nct_id>
  </id_info>
  <brief_title>Pre-Lens Tear Film Performance of Silicone Hydrogel Daily Disposable Contact Lenses</brief_title>
  <official_title>Randomized Cross-Over Evaluation of Silicone Hydrogel Daily Disposable Soft Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the pre-lens tear film stability of DAILIES TOTAL1®
      silicone hydrogel daily disposable contact lenses with that of two other silicone hydrogel
      daily disposable contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pre-Lens Non-Invasive Tear Break-Up Time (PL-NITBUT)</measure>
    <time_frame>Day 7, 16 hours after lens insertion</time_frame>
    <description>The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the corneal surface using a CA-1000 topographer, and the tear film reflection was observed on a 30-inch flat panel monitor. PL-NITBUT was recorded at the first sign of image distortion. Three measurements were taken and averaged together. A higher number represents a longer tear film break up time.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Dailies Total 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delefilcon A, followed by narafilcon A and filcon II 3 in randomized order. Each product worn for 1 week in a daily wear, daily disposable manner.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TruEye</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Narafilcon A, followed by delefilcon A and filcon II 3 in randomized order. Each product worn for 1 week in a daily wear, daily disposable manner.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clariti</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Filcon II 3, followed by narafilcon A and delefilcon A in randomized order. Each product worn for 1 week in a daily wear, daily disposable manner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delefilcon A contact lens</intervention_name>
    <description>Silicone hydrogel contact lens for single use, daily disposable wear.</description>
    <arm_group_label>Dailies Total 1</arm_group_label>
    <arm_group_label>TruEye</arm_group_label>
    <arm_group_label>Clariti</arm_group_label>
    <other_name>DAILIES® TOTAL1™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narafilcon A contact lens</intervention_name>
    <description>Silicone hydrogel contact lens for single use, daily disposable wear.</description>
    <arm_group_label>Dailies Total 1</arm_group_label>
    <arm_group_label>TruEye</arm_group_label>
    <arm_group_label>Clariti</arm_group_label>
    <other_name>1-DAY ACUVUE® TRUEYE™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Filcon II 3 contact lens</intervention_name>
    <description>Silicone hydrogel contact lens for single use, daily disposable wear</description>
    <arm_group_label>Dailies Total 1</arm_group_label>
    <arm_group_label>TruEye</arm_group_label>
    <arm_group_label>Clariti</arm_group_label>
    <other_name>Clariti™ 1-day</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be of legal age of consent and sign written Informed Consent document, or if under
             legal age, have written consent of parent or guardian to participate.

          -  Require vision correction in both eyes.

          -  Wear either daily disposable contact lenses or weekly/monthly replacement contact
             lenses in powers between -0.50 and -10.00 diopters, cylinder ≤0.75 diopter, no ADD
             correction.

          -  Wear habitual contact lenses an average of 12-14 hours per day, at least 5 days per
             week.

          -  Willing and able to wear study contact lenses 16 hours per day.

          -  Able to achieve visual acuity of at least 6/7.5 in each eye with study lenses.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Currently wearing DAILIES TOTAL1®, 1-DAY ACUVUE® TRUEYE™, or Clariti™ 1day contact
             lenses.

          -  Require monovision correction.

          -  Any systemic or ocular disease or disorder (refractive disorder allowed and dry eye
             permitted), complicating factors, or structural abnormality that would negatively
             affect the conduct or outcome of the study.

          -  Ocular surgery/trauma within the last 6 months.

          -  Topical or systemic antibiotic use within 7 days of enrollment.

          -  Topical ocular or systemic corticosteroid use within 14 days of enrollment.

          -  Pregnant and nursing women.

          -  Participation in any other ophthalmic drug or device clinical trial within 30 days of
             enrollment.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jami Kern, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <results_first_submitted>April 22, 2013</results_first_submitted>
  <results_first_submitted_qc>June 6, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 24, 2013</results_first_posted>
  <last_update_submitted>June 6, 2013</last_update_submitted>
  <last_update_submitted_qc>June 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>Contact Lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from one study center in the United Kingdom.</recruitment_details>
      <pre_assignment_details>This reporting group includes all enrolled participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Overall</title>
          <description>All enrolled participants</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All enrolled participants</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>DT1, TruEye, and Clariti contact lenses worn in randomized, cross-over fashion for one week each</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.1" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pre-Lens Non-Invasive Tear Break-Up Time (PL-NITBUT)</title>
        <description>The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the corneal surface using a CA-1000 topographer, and the tear film reflection was observed on a 30-inch flat panel monitor. PL-NITBUT was recorded at the first sign of image distortion. Three measurements were taken and averaged together. A higher number represents a longer tear film break up time.</description>
        <time_frame>Day 7, 16 hours after lens insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dailies Total 1</title>
            <description>Delefilcon A contact lenses worn for one week in a daily wear, daily disposable manner.</description>
          </group>
          <group group_id="O2">
            <title>TruEye</title>
            <description>Narafilcon A contact lenses worn for one week in a daily wear, daily disposable manner.</description>
          </group>
          <group group_id="O3">
            <title>Clariti</title>
            <description>Filcon II 3 contact lenses worn for one week in a daily wear, daily disposable manner.</description>
          </group>
        </group_list>
        <measure>
          <title>Pre-Lens Non-Invasive Tear Break-Up Time (PL-NITBUT)</title>
          <description>The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eye lid and the contact lens). The time required for a dry spot to appear on the corneal surface after blinking is referred to as the tear film break-up time. Circular images were projected onto the corneal surface using a CA-1000 topographer, and the tear film reflection was observed on a 30-inch flat panel monitor. PL-NITBUT was recorded at the first sign of image distortion. Three measurements were taken and averaged together. A higher number represents a longer tear film break up time.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.56" spread="3.7759121"/>
                    <measurement group_id="O2" value="12.0" spread="2.9676727"/>
                    <measurement group_id="O3" value="11.86" spread="3.5982819"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for the duration of the trial.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dailies Total 1</title>
          <description>Delefilcon A contact lenses worn for one week in a daily wear, daily disposable manner.</description>
        </group>
        <group group_id="E2">
          <title>TruEye</title>
          <description>Narafilcon A contact lenses worn for one week in a daily wear, daily disposable manner.</description>
        </group>
        <group group_id="E3">
          <title>Clariti</title>
          <description>Filcon II 3 contact lenses worn for one week in a daily wear, daily disposable manner.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jami Kern, PhD</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

